Aug 22, 2012 -- 7:10 amBy MICHELLE DIAMENT
August 21, 2012 Text Size A A
A new clinical trial is set to examine whether or not stem cells from a child’s own cord blood are an effective treatment for autism symptoms.
The study, which was announced Tuesday, is the first of its kind to win approval from the U.S. Food and Drug Administration.
Researchers said they plan to include 30 kids with autism ages 2 to 7. Each participant will receive two injections — one a placebo and the other containing stem cells from the child’s own cord blood — over the course of the 13-month trial. In an effort to limit bias, both the study participants and the lead investigators will not be told which injection is given at what time.
Scientists are looking to assess whether or not the stem cell infusion leads to improvements in behavior or language in children without any known cause for their autism diagnosis such as a genetic conditions like fragile X syndrome.
To read the entire article, please click: http://www.disabilityscoop.com/2012/08/21/in-fda-autism-stem-cell/16298/
< Back to article list